₹1,306.30
+₹43.90 (+3.48%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,083 Cr
P/E
19.25
ROE
18.06%
ROCE
23.58%
About 3B Blackbio DX Ltd
3D Blackbio DX is a leading Indian Biotechnology Company specializing in the Design, Development, Manufacturing, and Commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance. The company provides a comprehensive portfolio of qPCR-based assays, Rapid Tests and NGS-based molecular diagnostic kits for accurate and reliable testing on patient samples.
Founded
1972
CEO
D K Dubey
Employees
85
HQ
Bhopal, Madhya Pradesh
About 3B Blackbio DX Ltd
3D Blackbio DX is a leading Indian Biotechnology Company specializing in the Design, Development, Manufacturing, and Commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance. The company provides a comprehensive portfolio of qPCR-based assays, Rapid Tests and NGS-based molecular diagnostic kits for accurate and reliable testing on patient samples.
Founded:1972
CEO:D K Dubey
Employees:85
HQ:Bhopal, Madhya Pradesh
Finished Products
1Sales
₹127.85Cr2Export Sale
₹33.41CrRaw Materials
1Packing Material
₹44.57CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,442
52W Low
₹1,085
Volume15.97K
Avg VolumeN/A
Beta1.18
Dividend Yield0.40%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
19.25x
Valuation
P/B Ratio
3.34x
Valuation
EPS
₹65.56
Valuation
Dividend Yield
0.40%
Valuation
ROE
18.06%
Profitability
ROCE
23.58%
Profitability
Revenue by Segment
Contribution & growth by business line
Diagnostic kits
+38.5%87.4%
₹84.28 Cr
Agrochemicals
-11.0%12.6%
₹12.19 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.01x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
16.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.